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 Retinitis pigmentosa (RP) is a heterogeneous group of
inherited retinal degenerative diseases, characterized by the
progressive death of rod and cone photoreceptors leading to
an irreversible loss of visual function. The retinal degenera-
tion (rd1) mouse is an appropriate model for studying the cel-
lular and molecular events leading to photoreceptor death and
for evaluating new treatments as the pattern of photoreceptor
loss is similar to that in affected humans and because the mu-
tated gene encodes the β-subunit of rod cGMP-phosphodi-
esterase (Pde6b) [1] as in some affected human families [2].
However, to this day, mechanisms leading to photoreceptor
apoptosis still remain unsolved. It has recently been proposed
that, in the rd1 mouse retina, photoreceptor degeneration could
result from cumulative damage [3]. It is now well known that
the rd1 mutation results in cGMP accumulation in rods [4].
We can reasonably postulate that such a cGMP accumulation
may also induce a continuous depolarization of rod cells by
maintaining their cGMP-gated cationic channels open. The
subsequent activation of the voltage-sensitive calcium chan-
nels could then trigger a prolonged glutamate transmitter re-
lease. Changes in amino acid metabolism, and particularly
glutamate turnover, have been observed in several different
models of inherited retinal degeneration [5-10]. Ulshafer et
al. [5] were the first to demonstrate an increase in excitatory
amino acid levels (glutamate and aspartate) around degener-
ating photoreceptors in the GUCY1* chick. In the RCS rat,
Fletcher and Kalloniatis [6-8] observed an increase in aspar-
tate and glutamine levels (both of which are either precursors
or metabolites of glutamate), along with alterations in
glutamate and GABA manufacturing pathways supposedly
linked to abnormal Müller glial cell (MGC) function. In the
rds/rds mouse, an accumulation of glutamate has also been
observed in photoreceptor inner segments [9,10].
Glutamate toxicity has been demonstrated both on inner
retinal cells and on photoreceptor terminals [11-18]. In the
retina, glutamate homeostasis is maintained by the glial L-
glutamate/L-aspartate transporter (GLAST) and by glutamine
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Purpose: Kinetic studies of photoreceptor cell death in the retinal degeneration (rd1) mouse model suggest that photore-
ceptor degeneration could result from cumulative damage. Since alterations in glutamate metabolism have been described
in different models of retinitis pigmentosa, we investigated in the present work whether changes in glutamate turnover
occur in the degenerating rd1 retina and whether glutamate-mediated excitotoxic mechanisms may contribute to rod
photoreceptor death in this model.
Methods: Free amino acid levels were quantified in rd1 and wild-type retinas using an amino acid analyzer selecting
times corresponding to early, intermediate, and terminal phases of rod photoreceptor degeneration. Reverse transcription-
polymerase chain reaction (RT-PCR) was used to compare the mRNA expression levels of the glial L-glutamate/L-aspar-
tate transporter GLAST, glutamine synthetase (GS), and vimentin, a marker for retinal glia, between rd1 and wild-type
mouse retinas. 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), an antagonist of both AMPA and kainate subtypes of
ionotropic glutamate receptors, was then daily administered from postnatal day 3 (PN3) to PN21 to rd1 mice while control
rd1 mice received only physiological saline solution (7 per treatment). At PN22, the respective numbers of surviving rods
in CNQX- and saline-treated mice were estimated using an unbiased stereological approach.
Results: Gradual increases in free glutamate and glutamine levels were observed during photoreceptor degeneration in
rd1 retinas and were associated with increases in GLAST and GS expression levels. Administration of CNQX induced a
statistically significant morphological rescue of rods (>25%, p<0.05).
Conclusions: Our data demonstrated that, in the rd1 mouse retina, photoreceptor degeneration was associated with exces-
sive free glutamate levels and with an upregulation of glutamate turnover (i.e., increases in GLAST, GS, and free glutamine
levels). This may indicate that excessive glutamate levels further contribute to rod cell degeneration, thus implying the
occurrence of non-cell autonomous mechanisms in the degenerative process in the rd1 retina.
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688synthetase (GS), both being expressed in MGC [19-24]. Fine
tuning of glutamate uptake and degradation in glial cells is
essential to avoid neurotoxicity and to allow normal signal
transmission between photoreceptor and bipolar cells [19-21].
In the present work, we investigated whether alterations
in glutamate metabolism and glutamate-mediated excitotoxic
phenomena occur in the degenerating rd1 retina. The demon-
stration of such excitotoxic mechanisms could fit with the
cumulative damage hypothesis formulated by Clarke et al. [3].
We studied glutamate metabolism in rd1 and wild-type
retinas during the degeneration process by measuring free
amino acid levels using an amino acid analyzer. We next ana-
lyzed the endogenous response to the observed glutamate in-
crease in rd1 retina by studying expression levels of GLAST
and GS during retinal degeneration. Finally, we investigated
whether the observed glutamate increase in the rd1 retina could
contribute to photoreceptor cell death by evaluating the influ-
ence of a glutamate receptor antagonist on rod survival.
METHODS
Animals:  C3H/He mice (rd1 mice) and C57BL/6 mice (wild
type or controls) were obtained from Iffa Credo (L’Arbresle,
France). Animals were cared for and handled according to the
Association for Research in Vision and Ophthalmology
(ARVO) Statement for the Use of Animals in Ophthalmic and
Vision Research. They were maintained in clear plastic cages
and subjected to light/dark cycles of 12 h. Day of birth was
designated postnatal day 0 (PN0).
Quantification of free amino acids:  Retinas were rapidly
dissected on ice and deproteinized with 10% (w/v) trichloro-
acetic acid containing 0.5 mM EDTA. After sonication and
centrifugation, supernatants were collected and stored at -80
°C until amino acid analysis. Amino acids were separated and
quantified by ion-exchange chromatography using an amino
acid analyzer (AminoTac JLC-500/V; JEOL, Tokyo, Japan).
The concentrations of each amino acid are expressed, as a
percentage, with respect to the sum of all the concentrations
of the amino acids quantified by the analyzer (which included
taurine, threonine, serine, asparagine, glutamate, glutamine,
glycine, alanine, citrulline, valine, isoleucine, leucine, tyrosine,
phenylalanine, ornithine, lysine, and arginine).
Reverse transcription-polymerase chain reaction (RT-
PCR) analysis:  Ten retinas were pooled for each age (PN1,
PN8, PN15, PN35) and each strain (rd1 and control). Total
RNAs were purified from retinas by the cesium chloride cen-
trifugation method [25]. cDNAs were synthesized by reverse
transcription using random hexamers (pdN6) according to stan-
dard protocols. The sequence of each primer, the annealing
temperatures, the length of the amplified products, and the
GenBank accession numbers are given in Table 1.
Real-time PCRs were performed on a LightCycler instru-
ment (Roche-Diagnostics, Indianapolis, IN) and with SYBR
Green I, according to the manufacturer’s recommendations.
Cycling conditions were as follows: initial denaturation at 95
°C for 2 min, followed by 40 cycles of denaturation at 95 °C
for 0 s, annealing for 5 s (see Table 1 for annealing tempera-
tures) and elongation at 72 °C for 15 s. Melting curve analysis
was performed as follows: denaturation at 95 °C for 2 min,
annealing at 65 °C for 2 min, followed by a gradual increase
(0.1 °C/s) in temperature to 95 °C. Real-time PCR efficien-
cies were evaluated by calculating the slope of a linear regres-
sion graph following recommended protocols. For each ex-
periment, crossing points were calculated by the LightCycler
Data Analysis Program (LightCycler-3.5 Software). Target
gene expressions were normalized with respect to β-actin ex-
pression. Mean crossing point deviations were calculated be-
tween samples and controls as specified in the figures.
The amplification steps were performed in triplicate for
each point and were repeated using three independent cDNA
preparations. The levels of expression of rhodopsin, rod arrestin
and of other markers of retinal degeneration were tested and
found to be in accordance with the age and genotype analyzed,
thus validating our RNA preparations.
Protein extraction and western blotting:  rd1 and control
mice were killed at PN1, PN8, PN15, PN21, and PN35 (3
animals per age and strain). Eyes were immediately enucle-
ated, and retinas dissected within 2 min in sterile PBS. Reti-
nas were then homogenized in a lysis buffer containing 50
mM Tris-HCl pH 7.5, 1 mM PMSF, 1 mM EDTA, 1 mM
dithiothreitol, 1% Triton X-100, 1X mixture of protease in-
hibitors, 45 µg/ml TLCK, 1 mM sodium fluoride, and 1 mM
sodium orthovanadate. Protein concentrations were estimated
by Bradford’s technique [26]. Proteins were shock-frozen and
maintained at -80 °C until analysis. Proteins were further di-
luted 1:1 in sample buffer (final concentrations: 10 mM Tris-
HCl pH 8, 1 mM EDTA, 20 mM dithiothreitol, 3% SDS, 10%
glycerol, 0.1% bromophenol blue, 4 M urea) and heated at 50
°C for 45 min. Proteins (10 µg/lane) were separated by 10%
SDS-PAGE gel electrophoresis containing 4 M urea, and trans-
ferred onto nitrocellulose membranes. Membranes were
blocked with PBS, 0.1% Tween 20, 3% nonfat dry milk and
5% horse serum overnight at 4 °C and then incubated with
anti-GLAST antibody (1:15000) for 2 h at room temperature.
Membranes were then washed and incubated with the appro-
priate horseradish peroxidase-labeled secondary antibody
(1:15000; Jackson ImmunoResearch Laboratories, West
Grove, PA) for one hour at room temperature. Antibody bind-
ing was visualized by Enhanced Chemiluminescence detec-
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TABLE 1. RT-PCR CONDITIONS AND PRIMERS
                                           Annealing    Product    GenBank
               Forward and reverse        temperature   length    accession
  Gene           primer sequences            (°C)        (bp)      number
--------   ----------------------------   -----------   -------   ---------
β-actin    F: AAAGACCTCTATGCCAACACAG          57          296     M12481
           R: AAAGAAAGGGTGTAAAACGCAG
GLAST      F: GAAGTCTCCCAGACGTTCTAATCC        58          303     D63816
           R: GCTCTGAAACCGCCACTTACTATC
GLT-1      F: ATGCTCATCCTCCCTCTTATCATC        56          313     AB007810
           R: CTTTCTTTGTCACTGTCTGAATCTG
GS         F: TGTACCTCCATCCTGTTGCC            56          349     U09114
           R: GTCCCCGTAATCTTGACTCC
vimentin   F: TTTTGCCCTTGAAGCTGCTAAC          56          314     M26251
           R: TCACCTGTCCATCTCTGGTCT
This table lists the oligonucleotides used for RT-PCR with the corre-
sponding annealing temperatures, PCR product lengths, and GenBank
accession numbers. All these primers were used for real-time PCR.
689tion system (ECL+, Amersham, Arlington Heights, IL) as rec-
ommended by the manufacturer. To ensure that equal quanti-
ties were loaded in each lane, membranes were stripped and
subsequently reprobed with monoclonal anti-α-tubulin anti-
body (1:500; T5168, Sigma, Saint Louis, MO). Band intensi-
ties were quantified by scanning densitometry using Phoretix
1D software (Phoretix International, Newcastle-upon-Tyne,
UK).
Intraperitoneal injection of 6-cyano-7-nitroquinoxaline-
2,3-dione (CNQX):  CNQX was dissolved in a 0.9% NaCl
solution and injected intraperitoneally at a final concentration
of 15 mM. From PN3 to PN21, rd1 mice received intraperito-
neal injections of CNQX (30 mg/kg/day), whereas control rd1
mice were injected with an equivalent volume of physiologi-
cal saline solution (vehicle).
Electroretinogram recordings:  Electroretinograms
(ERGs) were recorded as described previously [27-29]. Post-
natal day 22 CNQX- and saline-injected rd1 mice were dark-
adapted for at least 16 h and anesthetized by intramuscular
injection of ketamine (100 mg/kg body weight) and xylazine
2% (10 mg/kg body weight). Pupils were dilated with 0.5%
tropicamide and the cornea was locally anesthetized with 0.5%
oxybuprocaine application. Body temperature was maintained
near 37 °C with a heating pad. Upper and lower lids were
retracted to proptose and maintain the eye open. Scotopic rod
ERGs were recorded in both eyes simultaneously by using a
gold loop electrode placed on the corneal surface maintained
with 3% methylcellulose gel (one electrode for each eye) and
referenced to a stainless steel reference electrode inserted sub-
cutaneously on the head of the animal. A needle electrode in-
serted in the tail served as ground. A 150 watt xenon lamp in a
Ganzfeld stimulator (Multiliner Vision, Jaeger Toennies, Ger-
many) provided the light stimulus (10 cds/m2). Ten record-
ings were averaged with an interstimulus interval of 120 s.
Rod immunolabeling and cell counting:  CNQX-injected
mice and saline-injected mice were sacrificed at PN22. Reti-
nas were removed and fixed in paraformaldehyde (4% in PBS)
for 2 h. They were rinsed in PBS, permeabilized in PBS con-
taining 0.1% Triton X-100 for 15 min, saturated in PBS con-
taining 0.1% bovine serum albumin and 0.1% Tween 20 for
20 min and then incubated overnight at 4 °C with a rod photo-
receptor-specific monoclonal antibody rho-4D2 (10 µg/ml; gift
from D. Hicks). After extensive rinsing, the primary antibody
was localized using goat anti-mouse IgG antibody coupled
with Alexa Fluor 594 (1:1000; Molecular Probes, Leiden,
Netherlands). Retinas were flat-mounted in a 50% PBS-glyc-
erol (1:1) solution with photoreceptors facing up and exam-
ined with a Nikon Optophot 2 Epifluorescence microscope.
Immunolabeled rods were then quantified using a stereologi-
cal approach permitting unbiased sampling as previously de-
scribed [30].
Statistical analysis:  All data are presented as the mean
and the standard error of the mean (SEM). Unpaired Student’s
t-test was used to compare amino acid levels in rd1 mice with
controls and to compare rod cell numbers in CNQX-treated
rd1 mice with saline-treated ones. Values of p<0.05 were con-
sidered to be significant.
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Figure 1. Free glutamate, glutamine, taurine, and glycine levels in
rd1 and control retinas during the degeneration process.  Free amino
acids were measured in rd1 and control retinas at PN4, PN8, PN15,
PN21, and PN35 using an amino acid analyzer. The concentrations
of each amino acid are expressed as a percentage with respect to the
sum of all the concentrations of the amino acids quantified by the
analyzer. Bars represent the mean (3 for each age and strain); the
error bars represent the standard error of the mean. A: Glutamate. B:
Glutamine. C: Taurine. D: Glycine.
690RESULTS
Alterations in amino acid metabolism during photoreceptor
degeneration in the rd1 retina: As alterations in amino acid
levels have already been described in some other models of
RP [5-10,31,32], we measured free amino acid levels in rd1
and control retinas selecting times corresponding to early, in-
termediate and terminal stages of degeneration. The existing
literature indicates that, first, PN8 most likely represents the
first time point when the degenerative process becomes de-
tectable in the rd1 mouse retina [4,33-37], second, PN35 can
be considered as the terminal stage of rod degeneration [38],
and third, PN15 and PN21 represent intermediate stages be-
tween the two. Figure 1 shows that, before the onset of degen-
eration (from PN4 to PN8), glutamine and glycine levels were
lower in rd1 retinas than in controls, whereas taurine levels
were moderately higher in rd1 retinas than in controls (PN4)
and glutamate levels were similar in both strains (PN4). At
the onset of degeneration (PN8), glutamate levels were slightly
higher in rd1 retinas, were comparable at PN15 and then
steadily increased from PN21 to PN35 with a 1.39 and 1.46
fold difference, respectively (Figure 1A). Glutamine levels
were significantly higher in rd1 retinas than in controls at
PN15, PN21 and PN35 with a 1.1-, 1.8 and 2.26 fold differ-
ence, respectively (Figure 1B). Taurine levels in control reti-
nas increased progressively from PN8 to PN35, whereas in
rd1 retinas they remained stable from PN8 to PN15 and then
slightly decreased (Figure 1C). Glycine levels increased
steadily from PN8 to PN35 in rd1 retinas, whereas they de-
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Figure 2. GLAST expression during
photoreceptor degeneration.
GLAST mRNA expression levels
were measured in retinas from un-
treated rd1 and control retinas dur-
ing photoreceptor degeneration.
Semi-quantitative analyses of
GLAST (A) and GLT-1 (B) mRNA
levels were measured using real-
time RT-PCR. Bars represent the
mean of triplicate determinations;
the error bars represent the standard
error of the mean. C: Western blots
of total protein (10 µg/lane) pre-
pared from rd1 and control retinas
at PN1, PN8, PN15, P21, and PN35,
and the blots were probed with anti-
GLAST and anti-α-tubulin antibod-
ies. The blots demonstrated bands
at about 50 kDa (α-tubulin), at about
76 kDa (GLAST monomeric form,
labeled 3), and two bands at about
160 kDa (GLAST multimeric
forms, labeled 1 and 2). Results are
representative of three independent
experiments.
691creased in controls (Figure 1D). These results indicate that
photoreceptor degeneration is associated with increases in free
glutamate, glutamine and glycine and with a decrease in free
taurine.
Photoreceptor degeneration induces GLAST
upregulation:  As glutamate excess has been shown to en-
hance the expression of GLAST [39-41], a key element in
glutamate clearance, we investigated whether the observed
increase in free glutamate during rod degeneration in the rd1
mouse retina (Figure 1A) was associated with a modification
in GLAST expression. We measured GLAST mRNA levels in
rd1 and control retinas from PN1 to PN35 by using real-time
RT-PCR, selecting times corresponding to early, intermediate
and terminal phases of degeneration. Figure 2A shows that at
PN1, before the onset of photoreceptor degeneration, no dif-
ference in GLAST mRNA expression was observed between
rd1 and control mice. At PN8, GLAST mRNA was 1.24 times
higher in rd1 retinas than in controls. At PN15, GLAST mRNA
was 2.15 times more abundant in rd1 retinas than in controls.
It remained at a similar level (2.25 fold difference) at PN35.
In contrast, at PN35, photoreceptor degeneration led to a 2.7
fold drop in the glutamate transporter GLT-1 mRNA expres-
sion (Figure 2B). This is consistent with GLT-1 being expressed
by retinal neuronal cells and more particularly by cones [42].
Western blot analyses (Figure 2C) confirmed that the amount
of GLAST protein increased throughout rod degeneration.
Though the amount of GLAST protein was the same in the
two strains at PN1, at PN8 GLAST was more abundant in the
rd1 mouse and the difference between the two strains increased
with time up to PN35. These results demonstrate that GLAST
expression increases right from the beginning (PN8) and gradu-
ally during the whole rod degeneration process.
Photoreceptor degeneration induces glutamine synthetase
upregulation:  Given that free glutamate and glutamine levels
are increased in rd1 retinas (Figure 1A,B) and that glutamine
synthetase (GS) catalyzes the amidation of glutamate to
glutamine, we studied GS mRNA levels in rd1 and control
retinas using real-time RT-PCR. GS mRNA levels were 1.3
fold and 1.52 fold higher in rd1 mouse retinas than in controls
at PN8 and PN15, respectively (Figure 3A). We also mea-
sured mRNA levels of vimentin, a marker for retinal glia, in
order to check whether the observed increase of GS (and pre-
viously of GLAST) did not reflect an increased number of
glial cells. No significant differences were observed in vimentin
mRNA levels between the two types of retinas at PN8 and
PN15 (Figure 3B).
AMPA/kainate-type glutamate receptor antagonist par-
tially rescues presynaptic rod photoreceptor cells:  To deter-
mine whether the observed free glutamate increase during reti-
nal degeneration (Figure 1A) participates to rod cell death in
the rd1 retina, we studied the effect of a glutamate receptor
antagonist (CNQX) on rod cell survival. CNQX or physiologi-
cal saline solution was daily injected intraperitoneally to rd1
mice from PN3 to PN21. At PN22, after a 16 h dark adapta-
tion period, scotopic rod ERGs were recorded from saline-
treated and CNQX-treated animals just before sacrifice. Reti-
nas were then dissected and immunolabeled with an antibody
©2005 Molecular Vision Molecular Vision 2005; 11:688-96 <http://www.molvis.org/molvis/v11/a81/>
Figure 3. Glutamine synthetase and vimentin mRNA expressions.
Glutamine synthetase (A) and vimentin (B) mRNA levels in rd1 and
control retinas at PN8 and PN15 were measured using real-time RT-
PCR. Bars represent the mean of triplicate determinations; the error
bars represent the standard error of the mean.
that specifically recognized rod photoreceptors. ERG record-
ings from saline-treated mice were all flat. Although some
recordings were detectable from CNQX-treated mice, data
from the whole number of animals studied were not statisti-
cally significant (data not shown). However, as shown in Fig-
ure 4A, a greater number of rods survived in CNQX-treated
rd1 mice in comparison with saline-treated mice. Quantifica-
tion of surviving rods on whole retinas using a stereological
692technique demonstrated that there were over 25% more rods
in CNQX-treated retinas (2.95 rods per field, SEM 0.50, n=7)
than in controls (2.35 rods per field, SEM 0.32, n=7; p<0.05,
Figure 4B). Hence, these results indicate that blocking AMPA/
kainate ionotropic glutamate receptors can promote morpho-
logical survival of rod photoreceptors in the rd1 mouse.
DISCUSSION
 Our results can be summarized as follows: (1) in the rd1 retina,
gradual increases in free glutamate and glutamine levels are
observed during photoreceptor degeneration and (2) are asso-
ciated with increases in GLAST and GS expression levels. (3)
Furthermore, administration of a glutamate receptor antago-
nist induces a statistically significant morphological rescue of
rods.
Alterations in glutamate metabolism during photorecep-
tor degeneration:  Alterations in amino acid metabolism have
been observed in several different models of inherited retinal
degeneration [5-10,31,32,43]. Decreases in taurine content and
increases in glycine content have previously been reported in
the rd1 mouse and in the RCS rat retinas [31,32,43]. The de-
crease in taurine (Figure 1C) can be explained by the loss of
photoreceptor cells that have been shown by immunohis-
tochemistry to exhibit high levels of this amino acid [7,31,43].
As for glycine (Figure 1D), its increase has been correlated in
the RCS rat to a high increase of glycine immunoreactivity in
bipolar cells [7]. Because bipolar cells obtain their glycine
from amacrine cells through gap junctions, the glycine increase
in bipolar cells has been proposed to be due to a change in gap
junction permeability [7]. Concerning glutamate levels, an
increase in excitatory amino acid levels around degenerating
photoreceptors was observed in the GUCY1* chick [5], in the
RCS rat [6-8] and in the rds/rds mouse [9,10]. In the rd1 mouse,
previous work by Orr and colleagues [43] studied glutamate
levels during photoreceptor degeneration (along with glycine,
taurine and GABA levels) but did not observe any differences
in glutamate concentrations between dystrophic and wild-type
retinas. Our results indicated an increase in free glutamate in
rd1 retinas with respect to controls (Figure 1A). Since our
findings concerning taurine and glycine levels were similar to
those reported by Orr et al. [43], the differences in glutamate
measurements cannot be explained by the normalization tech-
niques used (their results were expressed on a dry weight ba-
sis, whereas in the present study ours were expressed as a pro-
portion of the sum of all the amino acids quantified by the
amino acid analyzer, see Methods). The differences in the re-
sults are more likely due to the lower resolution of the quanti-
fication technique formerly used for glutamate analysis (this
technique being different from the ones used for taurine and
glycine measurements).
Considering that glutamate toxicity has been demonstrated
both on inner retinal cells and on photoreceptor terminals [11-
18], we next tried to determine whether the observed glutamate
increase could contribute to the rod cell degenerative process.
Evidence for glutamate-mediated toxicity on photorecep-
tors during retinal degeneration in the rd1 mouse retina: In
the central nervous system, fast excitatory neurotransmission
is mediated through glutamate acting on ionotropic glutamate
receptors [44]. Excessive activation of these receptors leads
to neuronal cell death [45]. We therefore studied the effect of
an ionotropic glutamate receptor antagonist on rod cell sur-
vival in order to know whether the observed glutamate in-
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Figure 4. Effect of CNQX on rod survival in the rd1 retina.  CNQX
or physiological saline solution was injected daily intraperitoneally
to rd1 mice from PN3 to PN21. After treatment, retinas were dis-
sected, immunolabeled with Rho-4D2, an antibody that specifically
recognized rod photoreceptors, and then flat-mounted. A: Views of
CNQX-treated and saline-treated retinas immunolabeled with Rho-
4D2 in an area surrounding the optic nerve head (same distance, same
parameters). The greater numbers of surviving rod photoreceptors
after CNQX treatment are apparent. The scale bars represent 25 µm.
B: Results of quantification of immunolabeled rods on whole retinas
using a stereological approach. Bars represent the mean (7 animals
in each group); the error bars represent the standard error of the mean
(an asterisk indicates p<0.05).
693crease may contribute to rod death. As shown in Figure 4,
CNQX-treated rd1 mice displayed morphological evidence of
rod photoreceptor rescue when compared to saline-treated
mice, especially in the area surrounding the optic nerve head.
However, such results may seem quite unexpected since
ionotropic glutamate receptors are not expressed by photore-
ceptors [46,47]. In photoreceptors, glutamate has only been
reported to elicit a current generated by a transporter coupled
to chloride channels [48,49] and to activate some metabotropic
receptors, thereby modulating intracellular calcium concen-
tration [50]. These pharmacological data indicate that the
CNQX-induced rod rescue cannot be attributed to a direct ef-
fect of CNQX on photoreceptors. Considering that expres-
sion of ionotropic glutamate receptors in the outer nuclear layer
is concentrated at the postsynaptic region, just opposite the
presumed site of photoreceptor glutamate release [46,47], our
results hence suggested that suppressing glutamate postsyn-
aptic excitation may slow down photoreceptor degeneration.
The possibility that glutamate excess may retrogradely affect
photoreceptors is further supported by acute and chronic
changes detected in photoreceptor outer segments and synap-
tic terminals following intravitreal injections of kainate in the
chicken eye [17].
The glutamate-mediated toxicity hypothesis in the rd1
mouse concurs with our finding that endogenous
neuroprotective mechanisms against glutamate toxicity dur-
ing rod degeneration were upregulated. Indeed, the two major
endogenous mechanisms to protect neurons from glutamate-
induced excitotoxicity in the retina and in the CNS are in-
creased glutamate uptake by the glial transporter GLAST [20]
along with the subsequent metabolism of glutamate into
glutamine by GS selectively expressed in glial cells [23,24].
GLAST expression levels were found to increase throughout
photoreceptor degeneration (Figure 2). Comparison of gene
expression profiles by microarray analysis in rd1 and wild-
type retinas further confirmed that the gene encoding GLAST
is one of the earliest and most highly upregulated genes in the
rd1 retina (data not shown). We also showed that GS mRNA
levels increase at PN8 and PN15 in rd1 retinas (Figure 3A),
whereas vimentin mRNAs, also expressed selectively by
MGCs in the retina, remain at similar levels in the two strains
(Figure 3B). The absence of difference in vimentin mRNA
expression between the two strains from PN8 to PN15 strongly
indicated that the increase in GS expression, and GLAST, re-
sult from neither MGC proliferation nor any concentration
phenomenon (due to photoreceptor degeneration) in our rd1
retina RNA preparations. The GS increase coincided with the
increase in free glutamine we observed in the rd1 mouse retina
from PN15 to PN35 (Figure 1B).
However, a persistent glutamate increase while GLAST
is upregulated may appear contradictory. Two main hypoth-
eses can be proposed to explain our findings.
First, Rossi et al. [51] reported that during severe ischemia,
glutamate release occurs mainly by reversed operation of neu-
ronal glutamate transporters. Although we cannot exclude such
a hypothesis, it seems rather unlikely in the present case since
GLAST was not expressed by neurons, and glutamine levels
were drastically elevated (Figure 1B). Such a production of
glutamine requires efficient capture of glutamate by MGCs
through the transporter GLAST, and the subsequent metabo-
lism of glutamate into glutamine via GS activity [24].
We tend to favor the following hypothesis. Glutamate has
been demonstrated to proportionally increase GLAST expres-
sion in brain-derived astroglial cultures, in primary cultures
of cortical astrocytes and recently in retinal MGC cultures [39-
41]. We thus propose that the early-observed glutamate in-
crease at PN8 induces GLAST upregulation in the rd1 retina
(Figure 1A and Figure 2). MGCs capture glutamate and con-
vert it into glutamine via GS activity, this neuroprotective
mechanism being efficient around PN15 (glutamate levels re-
turned to normal and glutamine levels increased, see Figure
1A,B). Eventually, later during the degenerative process (from
PN21 up to PN35), MGC capacity to maintain glutamate ho-
meostasis being overwhelmed, glutamate balance is disrupted
(Figure 1A).
Data from Fletcher and Kalloniatis [6] in the RCS rat retina
are in line with the latter hypothesis and provide a possible
explanation to the eventual incompetence of MGCs in main-
taining glutamate balance. By measuring high affinity uptake
of  3H-glutamate and the time course of degradation of
glutamate within MGC in the RCS retina, Fletcher and
Kalloniatis first demonstrated that 3H-glutamate uptake into
MGC is greater in the RCS rat retinas than in wild type, in line
with the GLAST increase we observed during photoreceptor
degeneration in the rd1 mouse retina (Figure 2). They next
showed that glutamate degradation is delayed within MGCs
in RCS retinas as compared to wild type. In the RCS rat, as
here in the rd1 mouse, this could be explained by the inhibi-
tion of GS activity as an indirect result of glutamine accumu-
lation (Figure 1B) [6,52].
In the CNS, neurotransmitter activity is crucial to regu-
late synaptic connectivity [53]. The precise role of glutamate
in the initial phase of synaptogenesis remains unclear, for ex-
ample, it could be involved in the stabilization of presynaptic
terminals [53]. Perturbation in glutamate levels during a criti-
cal period of development may therefore account for abnor-
mal synaptogenesis in the rd1 mouse. Blanks et al. [37] dem-
onstrated that the first detectable ultrastructural damage in the
rd1 mouse retina is a defective maturation of the outer synap-
tic layer where abnormal photoreceptor/bipolar cell synaptic
contacts are observed. These abnormalities are due to the fail-
ure of rod bipolar cells to develop the central element of the
post-synaptic triad, implying that the intercellular signaling
events necessary for successful contact, synapse formation,
and synapse consolidation are impaired in the rd1 mouse [54].
Thus, we propose that the mutation in the rd1 mouse resulting
in cGMP accumulation in rods [4] may also induce a continu-
ous depolarization of rod cells by maintaining their cGMP-
gated cationic channels open. Rod depolarization would then
trigger a sustained glutamate transmitter release resulting from
the activation of the voltage-sensitive calcium channels. The
imbalance of glutamate levels at the synaptic clefts might even-
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694tually compromise synaptic connectivity and thereby alter
subsequent maturation steps of photoreceptors [17,37]. This
may lead to “retrograde degeneration” of rods.
Therefore, our data pinpoint the occurrence of additive
non-cell autonomous mechanisms contributing to rod photo-
receptor death in the rd1 retina. Glutamate-mediated toxicity
may, at least partially, account for the “cumulative damage
hypothesis” put forward by Clarke and colleagues [3] in the
rd1 mouse. Blockade of retinal glutamate receptors undoubt-
edly represents, alone or combined with other therapies, a po-
tential therapeutic approach to prolong photoreceptor survival
in RP.
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